Role of bacterial infections in pancreatic cancer

Carcinogenesis

Volumn 34, Issue 10, 2013, Pages 2193-2197

  Michaud, Dominique S ^a,b  

^a BROWN UNIVERSITY   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CHRONIC PANCREATITIS; DIGESTIVE SYSTEM CANCER; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; GENETIC ASSOCIATION; GENETIC VARIABILITY; HELICOBACTER PYLORI; IMMUNE RESPONSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS CANCER; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REVIEW; SMOKING; STOMACH CANCER;

ABO BLOOD-GROUP SYSTEM; ANIMALS; BACTERIAL INFECTIONS; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; PANCREATIC NEOPLASMS; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84885093561     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt249     Document Type: Review

References (72)

1. American Cancer Society (2013) Cancer Facts & Figures 2013. American Cancer Society, Inc., Atlanta, GA.
2. Parkin, D.M. et al. (2011) 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br. J. Cancer, 105 (suppl. 2), S77-S81.
3. Lynch, S.M. et al. (2009) Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am. J. Epidemiol., 170, 403-413.
4. Genkinger, J.M. et al. (2011) A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int. J. Cancer, 129, 1708-1717.
5. Aune, D., et al. (2012) Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann. Oncol., 23, 843-852.
6. Ben, Q., et al. (2011) Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur. J. Cancer, 47, 1928-1937.
7. Gapstur, S.M., et al. (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA, 283, 2552-2558.
8. Stolzenberg-Solomon, R.Z., et al. (2005) Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA, 294, 2872-2878.
9. Duell, E.J., et al. (2012) Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann. Oncol., 23, 2964-2970.
10. Arcavi, L., et al. (2004) Cigarette smoking and infection. Arch. Intern. Med., 164, 2206-2216.
11. Barbour, S.E., et al. (1997) Tobacco and smoking: environmental factors that modify the host response (immune system) and have an impact on periodontal health. Crit. Rev. Oral Biol. Med., 8, 437-460.
12. Vlachojannis, C., et al. (2010) Determinants of serum IgG responses to periodontal bacteria in a nationally representative sample of US adults. J. Clin. Periodontol., 37, 685-696.
13. Milner, J.J., et al. (2012) The impact of obesity on the immune response to infection. Proc. Nutr. Soc., 71, 298-306.
14. Knapp, S. (2013) Diabetes and infection: is there a link?-A mini-review. Gerontology., 59, 99-104.
15. Dasu, M.R., et al. (2012) Toll-like receptors and diabetes: a therapeutic perspective. Clin. Sci. (Lond.), 122, 203-214.
16. Greer, J.B., et al. (2009) Inflammation and pancreatic cancer: an evidencebased review. Curr. Opin. Pharmacol., 9, 411-418.
17. Lowenfels, A.B., et al. (1993) Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N. Engl. J. Med., 328, 1433-1437.
18. Malka, D., et al. (2002) Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut, 51, 849-852.
19. Talamini, G., et al. (1999) Incidence of cancer in the course of chronic pancreatitis. Am. J. Gastroenterol., 94, 1253-1260.
20. Lowenfels, A.B., et al. (1997) Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J. Natl Cancer Inst., 89, 442-446.
21. Chari, S.T., et al. (1994) Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study. Pancreas, 9, 62-66.
22. Raderer, M., et al. (1998) Association between Helicobacter pylori infection and pancreatic cancer. Oncology, 55, 16-19.
23. Stolzenberg-Solomon, R.Z., et al. (2001) Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J. Natl Cancer Inst., 93, 937-941.
24. de Martel, C., et al. (2008) Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol. Biomarkers Prev., 17, 1188-1194.
25. Lindkvist, B., et al. (2008) A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer, 8, 321.
26. Risch, H.A., et al. (2010) ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J. Natl Cancer Inst., 102, 502-505.
27. Trikudanathan, G., et al. (2011) Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP, 12, 26-31.
28. Bao, Y., et al. (2010) History of peptic ulcer disease and pancreatic cancer risk in men. Gastroenterology, 138, 541-549.
29. Luo, J., et al. (2007) The risk of pancreatic cancer in patients with gastric or duodenal ulcer disease. Int. J. Cancer, 120, 368-372.
30. Papapanou, P.N. (1996) Periodontal diseases: epidemiology. Ann. Periodontol., 1, 1-36.
31. Tribble, G.D., et al. (2013) Genetic diversity in the oral pathogen Porphyromonas gingivalis: molecular mechanisms and biological consequences. Future Microbiol., 8, 607-620.
32. Stolzenberg-Solomon, R.Z., et al. (2003) Tooth loss, pancreatic cancer, and Helicobacter pylori. Am. J. Clin. Nutr., 78, 176-181.
33. Hujoel, P.P., et al. (2003) An exploration of the periodontitis-cancer association. Ann. Epidemiol., 13, 312-316.
34. Michaud, D.S., et al. (2007) A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J. Natl Cancer Inst., 99, 171-175.
35. Ahn, J., et al. (2012) Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis, 33, 1055-1058.
36. Joshipura, K.J., et al. (1996) Validity of a self-reported periodontal disease measure. J. Public Health Dent., 56, 205-212.
37. Michaud, D.S., et al. (2012) Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut. http://gut.bmj.com/content/early/2012/09/17/gutjnl-2012-303006.abstract (5 August 2013, date last accessed).
38. Fox, J.G., et al. (2010) Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut, 59, 88-97.
39. Rogers, A.B. (2011) Distance burning: how gut microbes promote extraintestinal cancers. Gut Microbes, 2, 52-57.
40. Risch, H.A. (2003) Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J. Natl Cancer Inst., 95, 948-960.
41. Risch, H.A. (2012) Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group. Mol. Carcinog., 51, 109-118.
42. Nair, J., et al. (1996) Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users. Crit. Rev. Toxicol., 26, 149-161.
43. Shapiro, K.B., et al. (1991) Quantitative relationship between oral nitratereducing activity and the endogenous formation of N-nitrosoamino acids in humans. Food Chem. Toxicol., 29, 751-755.
44. Joshipura, K.J., et al. (2004) Periodontal disease and biomarkers related to cardiovascular disease. J. Dent. Res., 83, 151-155.
45. Joshipura, K., et al. (2003) Periodontal disease and biomarkers related to cardiovascular disease (abstract). J. Dent. Res., 82, B-247.
46. Hayashi, C., et al. (2010) Review: pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cellspecific innate immune inflammatory pathways. Mol. Oral Microbiol., 25, 305-316.
47. Padilla, C., et al. (2006) Periodontal pathogens in atheromatous plaques isolated from patients with chronic periodontitis. J. Periodontal Res., 41, 350-353.
48. Cavrini, F., et al. (2005) Molecular detection of Treponema denticola and Porphyromonas gingivalis in carotid and aortic atheromatous plaques by FISH: report of two cases. J. Med. Microbiol., 54, 93-96.
49. Haraszthy, V.I., et al. (2000) Identification of periodontal pathogens in atheromatous plaques. J. Periodontol., 71, 1554-1560.
50. Rakoff-Nahoum, S., et al. (2009) Toll-like receptors and cancer. Nat. Rev. Cancer, 9, 57-63.
51. Zhang, J.J., et al. (2010) Expression and significance of TLR4 and HIF- 1alpha in pancreatic ductal adenocarcinoma. World J. Gastroenterol., 16, 2881-2888.
52. Ikebe, M., et al. (2009) Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway. J. Surg. Oncol., 100, 725-731.
53. Ochi, A., et al. (2012) MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J. Exp. Med., 209, 1671-1687.
54. Ochi, A., et al. (2012) Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. J. Clin. Invest., 122, 4118-4129.
55. Feig, C., et al. (2012) The pancreas cancer microenvironment. Clin. Cancer Res., 18, 4266-4276.
56. Tang, D., et al. (2013) Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Int. J. Cancer, 132, 993-1003.
57. Iorio, M.V., et al. (2012) microRNA involvement in human cancer. Carcinogenesis, 33, 1126-1133.
58. Bartel, D.P. (2009) MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-233.
59. Esquela-Kerscher, A., et al. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
60. Virtue, A., et al. (2012) MicroRNAs and Toll-like receptor/interleukin-1 receptor signaling. J. Hematol. Oncol., 5, 66.
61. Benakanakere, M.R., et al. (2009) Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. J. Biol. Chem., 284, 23107-23115.
62. Moffatt, C.E., et al. (2011) Porphyromonas gingivalis induction of micro- RNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells. Infect. Immun., 79, 2632-2637.
63. Valadi, H., et al. (2007) Exosome-mediated transfer of mRNAs and micro-RNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol., 9, 654-659.
64. Rechavi, O., et al. (2009) Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. Genes Dev., 23, 1971-1979.
65. Zhang, Y., et al. (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell, 39, 133-144.
66. Amundadottir, L., et al. (2009) Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat. Genet., 41, 986-990.
67. Wei, P., et al. (2012) Insights into pancreatic cancer etiology from pathway analysis of genome-wide association study data. PLoS One, 7, e46887.
68. Wolpin, B.M., et al. (2009) ABO blood group and the risk of pancreatic cancer. J. Natl Cancer Inst., 101, 424-431.
69. Wolpin, B.M., et al. (2010) Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res., 70, 1015-1023.
70. Wolpin, B.M., et al. (2010) Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol. Biomarkers Prev., 19, 3140-3149.
71. Wang, D.S., et al. (2012) ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int. J. Cancer, 131, 461-468.
72. Paré, G., et al. (2008) Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet., 4, e1000118.